
afib.no - the Norwegian AF research network
@AfibNo
Followers
63
Following
23
Media
11
Statuses
21
The Norwegian Atrial Fibrillation Research Network aims to inspire & motivate for even better AF research across centers in- and outside Norway
Norway
Joined October 2023
Important overview of genetic testing in early-onset AF. @Gene_Doctor_ and co-leader of is thankful for being part of this brilliant review in EHJ.
afib.no
Have you ever considered genetic testing in pts with early-onset AF (<45 years) as an EP? Probably not, maybe you should. In our recent state-of-the-art review @ehj_ed we discuss implementation of genetic testing in AF clincial care. #EPeeps #CardioTwitter. A thread🧵
0
0
1
RT @MariusMyrstad: Had a great time with leading AF-researcher Michiel Rienstra from Groningen who visited our department at Bærum Hospital….
0
2
0
RT @trygve_berge: @MariamAnjumMD @ESC_Journals Supplemented by an insightful Editorial; is the grey zone becoming less grey? .
academic.oup.com
This editorial refers to ‘Stroke and bleeding risk in atrial fibrillation with CHA2DS2-VASC risk score of one: the Norwegian AFNOR study’, by M. Anjum et a
0
3
0
RT @trygve_berge: NOW: Proud to present the results of @MariamAnjumMD and our AFNOR study in @ESC_Journals. Should AF patients at intermedi….
academic.oup.com
AbstractBackground and Aims. The benefit of oral anticoagulant (OAC) therapy in atrial fibrillation (AF) and intermediate stroke risk is debated. In a nati
0
3
0
RT @atrialstrain: Congrats to @eivindso who brilliantly defended his thesis for the PhD today 🤩👏🫀@UniOslo_MED @VestreViken .
0
4
0
RT @Gene_Doctor_: Proud of @mortenmattings2 presenting WGS data from the GENAF study at #AHA23 today! Deleterious TTN variants is associate….
0
3
0
RT @MariusMyrstad: The low number of female athletes is a main limitation. It isn't easy, but with commitment from researchers and targeted….
0
4
0
RT @MariusMyrstad: Does vigorous endurance exercise cause #Afib in women? Despite low prevalence of risk factors, we found a relatively hig….
0
24
0
@kajsastraat @drjohnm @Jocasta_Ball @hakonkornstad Sorry for the typo! The best oral abstract award went to Dr. Melodié Schneider! In a close race with the other presenters 🤩.
0
0
0
The last session of the year - screening for AF. @SZDiederichsen - the Loop study, dr. Miroslav Boskovic & @sighalvo - NORSCREEN & @AnneHegeAamodt - the NORFIB study discussed who to screen - or not to screen for AF
1
1
7
Day 2 started with an impressive session on the genetics of AF, cardioembolic stroke & atrial cardiomyopathy. @SallingOlesen, dr. Michiel Rienstra & @mortenmattings2 gave brilliant lectures on data from Denmark, the Netherlands and Norway
1
0
4
The best oral abstract presentation award went to @kajsastraat; the best poster award went to dr. Jonatan Fernstad. The awards were presented by @drjohnm, @Jocasta_Ball & dr Sam Franklin. @hakonkornstad mesmerized us with his jazz saxophone and his operatic tenor 🎷🎶
2
1
7
The abstract session was a highlight, as always! 6 presenters showed impressive results from Denmark, Sweden and Norway: @LSoattin, @arnelasaljic, @JohanEngdahl2, Dr. Melodié Schneider, .
1
1
5
Distinguished keynote speaker, @drjohnm reminded us to stay critical when interpreting the results of research, whether it is performed at our own insitution or published in the highest ranked journals. Thanks for coming all the way to Oslo to join our discussions!
1
0
4
Dr. Katja Sharashova showed AF epi results from the Tromsø study, @pselmer presented left atrium echo data from the ACE1950 study, dr. Morooka showed results on parity & risk of AF in the HUNT study, @trygve_berge introduced the new RegTool AFNOR study.
1
0
6
Thanks again for the wonderful 7th annual meeting at Lysebu in Oslo, Norway. The organizers (dr. Arnljot Tveit,@KFolkenborg & @Gene_Doctor_) are grateful for the contributions of our members and invited speakers! Recap from the inspiring sessions below 👇
1
3
10